| Fluorescence microscopy—an outline of hardware, biological handling, and fluorophore considerations SM Hickey, B Ung, C Bader, R Brooks, J Lazniewska, IRD Johnson, ... Cells 11 (1), 35, 2021 | 76 | 2021 |
| Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy? LY Tan, C Martini, ZG Fridlender, CS Bonder, MP Brown, LM Ebert Clinical & Translational Immunology 6 (3), e134, 2017 | 28 | 2017 |
| Platelets disrupt vasculogenic mimicry by cancer cells C Martini, EJ Thompson, SR Hyslop, MP Cockshell, BJ Dale, LM Ebert, ... Scientific reports 10 (1), 5869, 2020 | 27 | 2020 |
| CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix C Martini, M DeNichilo, DP King, MP Cockshell, B Ebert, B Dale, LM Ebert, ... BMC cancer 21, 1-14, 2021 | 23 | 2021 |
| Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer C Martini, JM Logan, A Sorvina, C Gordon, AR Beck, BSY Ung, ... Pathology 55 (1), 40-51, 2023 | 21 | 2023 |
| Pitfalls in cutaneous melanoma diagnosis and the need for new reliable markers GT Lam, S Prabhakaran, A Sorvina, C Martini, BSY Ung, L Karageorgos, ... Molecular Diagnosis & Therapy 27 (1), 49-60, 2023 | 13 | 2023 |
| Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression J Lazniewska, KL Li, IRD Johnson, A Sorvina, JM Logan, C Martini, ... Scientific reports 13 (1), 13489, 2023 | 11 | 2023 |
| Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-assisted grading using Appl1, Sortilin and Syndecan-1 JM Logan, AM Hopkins, C Martini, A Sorvina, P Tewari, S Prabhakaran, ... Cancers 15 (12), 3215, 2023 | 10 | 2023 |
| Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread A Sorvina, C Martini, S Prabhakaran, JM Logan, BSY Ung, C Moore, ... Pathology 55 (6), 792-799, 2023 | 8 | 2023 |
| Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression BD Nturubika, CM Guardia, DC Gershlick, JM Logan, C Martini, JK Heatlie, ... British Journal of Cancer 131 (8), 1263-1278, 2024 | 4 | 2024 |
| Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: a spotlight on the contribution of the endosome-lysosome system J Tang, GT Lam, RD Brooks, M Miles, Z Useckaite, IRD Johnson, ... Cancer Letters 585, 216639, 2024 | 4 | 2024 |
| Insights into melanoma clinical practice: a perspective for future research GT Lam, C Martini, T Brooks, S Prabhakaran, AM Hopkins, BSY Ung, ... Cancers 15 (18), 4631, 2023 | 3 | 2023 |
| Altered endosomal-lysosomal biogenesis in melanoma GT Lam, A Sorvina, C Martini, S Prabhakaran, BSY Ung, J Lazniewska, ... Neoplasia 43, 100924, 2023 | 3 | 2023 |
| P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer M Bates, D Mullen, E Lee, D Costigan, EA Heron, N Kernan, ... Pathology-Research and Practice 253, 155020, 2024 | 2 | 2024 |
| Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers JM Logan, C Martini, A Sorvina, IRD Johnson, RD Brooks, MC Caruso, ... Scientific Data 11 (1), 852, 2024 | 1 | 2024 |
| Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer C Martini, JM Logan, A Sorvina, S Prabhakaran, BSY Ung, IRD Johnson, ... Virchows Archiv, 1-6, 2023 | 1 | 2023 |
| Dynamic interplay between sortilin and syndecan-1 drives a metabolic switch during prostate cancer progression J Lazniewska, KL Li, I Johnson, A Sorvina, J Logan, C Martini, C Moore, ... | | 2023 |
